drugset / Trial / NCT02516085
Improved Muscle Function in Duchenne Muscular Dystrophy Through L-Arginine and Metformin
NaSingle-groupOpen-labelTreatment
Summary
The purpose of the study is to show that the intake of L-arginine and metformin improves muscle function and delays disease progression in patients with Duchenne's muscular dystrophy.
Timeline
- Start
- 2012-01
- Primary completion
- 2012-10
- Completion
- 2012-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | L-arginine | Small molecule | 2.5 g | Oral |
| Subject | Metformin | Small molecule | 250 mg | Oral |